Coagulation-fibrinolysis abnormalities in patients receiving antiparkinsonian agents.

Sato, Yoshihiro; Kaji, Masahide; Metoki, Norifumi; Yoshida, Hidemi; Satoh, Kei

Sato, Yoshihiro; Kaji, Masahide; Metoki, Norifumi; Yoshida, Hidemi; Satoh, Kei.

Affiliation

Sato Y; Department of Rehabilitation Medicine, Institute of Brain Science, Hirosaki University School of Medicine, Hirosaki 036-8562, Japan. y-sato@ktarn.or.jp

J Neurol Sci ; 212(1-2): 55-8, 2003 Aug 15.

Article in En | MEDLINE | ID: mdl-12809999

Subject(s)

Antiparkinson Agents/adverse effects; Blood Coagulation Disorders/chemically induced; Fibrinolysis/drug effects; Aged; Antifibrinolytic Agents/blood; Antiparkinson Agents/therapeutic use; Blood Coagulation Disorders/metabolism; Case-Control Studies; Dopamine Agents/adverse effects; Dopamine Agents/therapeutic use; Drug Therapy, Combination; E-Selectin/blood; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysin; Humans; International Normalized Ratio/methods; Levodopa/adverse effects; Levodopa/therapeutic use; Male; Middle Aged; Neuroleptic Malignant Syndrome/etiology; Neuroleptic Malignant Syndrome/metabolism; Parkinson Disease/complications; Parkinson Disease/drug therapy; Parkinson Disease/metabolism; Peptide Fragments/blood; Prothrombin; Thrombomodulin/blood; alpha-2-Antiplasmin

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Blood Coagulation Disorders / Fibrinolysis / Antiparkinson Agents Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Neurol Sci Year: 2003 Document type: Article Affiliation country: Japan Country of publication: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links